Navigation Links
Progress Against Malaria: Developments on the Horizon
Date:10/1/2007

October 24, 2007
1 p.m. to 7:30 p.m.
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th Floor
New York, NY 10007

The Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health and The New York Academy of Sciences present Progress Against Malaria: Developments on the Horizon, a half-day symposium to highlight the latest research developments in the fight to combat malaria. This meeting will include discussions of new diagnostic tests, treatment and prevention strategies, and malaria-resistant mosquitoes. The symposium will also feature work from Macha, Zambia, where malaria research is conducted in a unique rural setting.

Online registration is available at www.nyas.org/mraconf. To register by phone or to request accommodations for a disability, call 212-298-8615.

WEDNESDAY, OCTOBER 24, 2007 1:00 PM 5:30 PM

1:00 pm 2:00 pm Registration

2:00 pm 2:15 pm Welcome and Introduction
Ellis Rubinstein, President, The New York Academy of Sciences

2:15 pm 2:45 pm KEYNOTE LECTURE
Current Developments in Malaria Product Innovation and Control
Chris Hentschel, Ph.D., President and Chief Executive Officer, Medicines for Malaria Venture

2:45 pm 3:25 pm SESSION I: The State of the Art and Beyond:
Vaccine Development and Creation of Malaria-Resistant Mosquitoes

Mosquitoes That Cant Get Infected
Marcelo Jacobs-Lorena, Ph.D., Johns Hopkins Malaria Research Institute

Progress and Challenge in the Development of a Malaria Vaccine:
The PATH MVI Perspective
Christian Loucq, M.D., Director, The PATH Malaria Vaccine Initiative

3:25 pm 3:45 pm Coffee Break

3:45 pm 4:45 pm SESSION II: Progress in Diagnosis, Prevention and Treatment
Moderator: Diane Griffin, Ph.D., M.D., Johns Hopkins Bloomberg School of Public Health
'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
2. Disease progression model of pancreatic cancer developed by Penn researchers
3. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
4. Progress on HIV/AIDS significant but insufficient
5. Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
6. Genome changes tracked during multiple myeloma initiation, progression and treatment
7. Iraqs marshes show progress toward recovery
8. Progress being made in exploring potential use of stem cells to treat heart disease
9. Researchers make progress in studying genetic traits of India-born populations
10. Insulin receptor stops progression of Alzheimers disease
11. Progress made in HIV vaccine development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ic corridors in the cities of Long Beach and River...of preventable childhood asthma, and the true impa...ase has likely been underestimated, according to r...a (USC). , The study, which appears in an onlin...h , estimated that nine percent of all childhood a...
(Date:11/4/2009)...ity of Oklahoma at Norman has received more than $...encies as part of the federal stimulus program, br...d by OU researchers to $23 million. Thirty-three ...ging from archaeology to weather. , "The univers...ach to matching areasof scholarly excellence to fe...
(Date:11/4/2009)..., Mass., Oct. 20 Aware, ...band technology and biometrics software, today rep...ed September 30, 2009. ,, Michael Tzannes, Aw..."Earlier today, we announced an agreement to sell ...q, a new fabless semiconductor company being spun ...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 1NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 1Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 2Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 3
..., Pterosaurs have long suffered an identity crisi...se extinct flying lizards in with dinosaurs. Even ... flew, they were birdlike in many ways, such as us...what is believed to be first-time evidence that la...ght required pterosaurs to use four limbs: two wer...
..., CHICAGO The January issue of the Journal of t...h studies focusing on everyday eating habits of co...not always meet the nutritional needs of preschool...nfluences diets of young adults. , Packing a Lun...oximately 13 million children in the United States...
..., Stanford, CAA lack of technology needed to expl...st has been a critical bottleneck for Earth scient...result, we have limited understanding of the compo...are responding to clearing, invasive plants, clima...s team at the Carnegie Institution,s Department of...
Other Biology News:Four, three, two, one . . . pterosaurs have lift off 2News from the January 2009 Journal of the American Dietetic Association 2New rainforest mapping technology gets huge support 2
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/6/2009)...nda for Arrowhead’s 2010 Personalized Medici...lace on February 22-24, 2010 in Philadelphia, has ...ll highlight key issues in forming partnerships an...ces. , Minneapolis, MN (P...’s 2010 Personalized Medicine Partnerships ...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009)...RNewswire/ -- DSM Pharmaceutical Products today an...with Galenix, Saint Jean D,Illac, France, where DS...ring partner for Galenix commercial products on a ...te on business development opportunities co-market...he strength of Galenix in drug product development...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...cess to 'Best Practices for Long-term Jatroph... Rajagopal's highly successful November 2007 ...ck: Jatropha: A Strategic Option', is being o...bility criterion for Jatropha as it nears commerci...ey points outlined in Dr. R. Rajagopal's late...
...edigree Pups Can Now Bark Up Family Tree with DNA ...B) July 10, 2008 -- Barking up the family tree has...ng for mixed-pedigree pups now available to pet pa...ialty retailer., , , , ,Beginning Tuesday, July 15...ine Heritage Breed Test (CHBT) and the newly expan...
..., MELBOURNE, Australia, July 10 Cytopia (ASX: CY...verett as Chief Scientific,Advisor to the company.... closely with the,company,s executive management t...ide scientific leadership and guidance. He has hel...rroughs Wellcome and in recent,years, at Valeant P...
Other Biology Technology:Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 2Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 3Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 4PETCO Adds Canine Heritage Breed Test to its Innovative Assortment 2PETCO Adds Canine Heritage Breed Test to its Innovative Assortment 3PETCO Adds Canine Heritage Breed Test to its Innovative Assortment 4Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist 2
... Display Cloning System facilitates the display of...iophage M13 as coat protein fusions, creating a ph...its encoding DNA sequence. Peptide ligands for a v...ightforward method of biopanning. The supplied dis...
...ul cell culture or fermentation is the ability to ...nd make rapid adjustments in response to changes i...zers provide immediate analysis of key nutrients, ...ation media. BioProfile analyzers are fully automa...
...yolk protein Vtg in plasma from juvenile or male f...ine disrupting chemicals (EDCs) with estrogenic ef... accepted screening test for the estrogenic effect... is a double-antibody immunometric (sandwich) EIA ...
...s over 23 years of experience in the development o...o large and small peptides, proteins, haptens, car...mid DNA-encoded antigens. We understand and apprec...a development programs are never "cookbook". We wi...
Biology Products: